Park Medi World Limited share price

Key numbers

Market cap

₹ 12,368 Cr

Current price

₹ 286.35

52-week high / low

₹ 305 / 138

Stock P/E

43.7

Book value

₹ 50.8

Dividend yield

0.00%

ROCE

19.8%

ROE

16.8%

Debt to equity

0.18

Sales growth (3 yrs)

9.6%

Profit growth (3 yrs)

5.5%

1-year return

-

About Park Medi World Limited

Park Medi World Limited operates a network of hospitals. The company provides cardiac sciences, neurosciences - brain and spine, plastic and cosmetic surgery, general and laparoscopic surgery, renal sciences and kidney transplant, bone, orthopaedics, joint replacement and sports medicine, gastroenterology and surgical gastroenterology, cancer care, bone marrow transplant, iMARS / robot-assisted surgery. It also offers bariatric surgery, anaesthesiology, critical care, chest and respiratory diseases, dental care, dermatology, endocrinology, paediatrics, internal medicine and geriatrics, rheumatology, ENT, ophthalmology, obstetrics and gynaecology, interventional radiology and imaging, psychiatry, pathology and microbiology, paediatric surgery, fertility management, nuclear medicine services. It operates NABH accredited multi-super specialty hospitals under the Park brand name. Park Medi World Limited was founded in 2005 and is headquartered in Gurugram, India.

Quarterly results

Consolidated figures in ₹ crores

Concall summary (2026-08-08)

AI summary of the earnings call transcript · tone: Positive · source document

Guidance & outlook

• We expect full-year FY'27 occupancy to moderate from the FY'26 figures of 64%, largely on account of the addition of significant new capacity of 1,490-beds in calendar year 2026.
• On the CGHS rate revision, while we had guided conservatively to a 7% to 7.5% benefit flowing into FY'27, we continue to expect the fuller impact to be visible from Q2 of the financial year as the revised rates percolate through allied central government agencies.

Growth & demand

• We reported revenue from operations of Rs.476 crores, year -on-year growth of 19%.
• EBITDA, excluding other income, stood at Rs.126 crores, year-on-year growth of 20%, with a margin of 26.5%.

Margins & costs

• PAT came in at Rs.89 crores, year -on-year growth of 35%, with a margin of 18.6%.
• PAT for the quarter was Rs.89 crores, with a PAT margin of 18.6%, an expansion of 220 basis points year-on-year.

Capex & expansion

• Taken together, our capacity addition during calendar year 2026 will be total 1,490 beds, an increase of 46% over our calendar year 2025, capacity of 3 ,250 beds.
• CAPEX and acquisition spend through the quarter was directed largely towards the Rudrapur acquisition, ongoing N arela commissioning costs and equipment upgrade across the network.

Balance sheet & cash

• PAT margin expansion was largely on account of reduction in interest outgo following the substantial repayment of term debt over the past year.
• On the balance sheet, our term debt Park Medi World Limited August 04, 2026 excluding lease liability stood at Rs.25.6 crores as of 30th June 2026, as against Rs.28.2 crores as of 31, March 2026.

Peers in Medical Care Facilities

• Apollo Hospitals Enterprise Limited
• Max Healthcare Institute Limited
• Manipal Health Enterprises Limited
• Aster DM Quality Care Limited
• Fortis Healthcare Limited
• Global Health Limited
• Narayana Hrudayalaya Limited
• Krishna Institute of Medical Sciences Limited
• Rainbow Children's Medicare Limited
• Yatharth Hospital & Trauma Care Services Limited